Cefiderocol (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cefiderocol" in German language version.

Last modified:

Ref.Un. Ref.Website
Global rank German rank
5th place
7th place
470th place
765th place
2nd place
3rd place
10th place
633rd place
low place
low place
62nd place
21st place
low place
730th place
213th place
245th place
low place
1,049th place
7,932nd place
low place

ambeed.com (Global: low place; German: low place)

deutsche-apotheker-zeitung.de (Global: low place; German: 1,049th place)

doi.org (Global: 2nd place; German: 3rd place)

  • Stella Babich, Pier Giorgio Cojutti, Milo Gatti, Federico Pea, Stefano Di Bella, Jacopo Monticelli: Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis. In: JAC-Antimicrobial Resistance. Band 7, Nr. 3, 29. April 2025, doi:10.1093/jacamr/dlaf066, PMC 12050970 (freier Volltext).
  • T. Sato, K. Yamawaki: Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin. In: Clinical Infectious Diseases. Band 69, Supplement 7. November 2019, S. S538–S543, doi:10.1093/cid/ciz826, PMID 31724047, PMC 6853759 (freier Volltext).
  • T. Tängdén, C. G. Giske: Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. Journal of Internal Medicine, Band 277 (2015), S. 501-12.T, doi:10.1111/joim.12342
  • Robert A Bonomo: Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens. In: Clinical Infectious Diseases. Band 69, Supplement_7, 13. November 2019, S. S519–S520, doi:10.1093/cid/ciz823, PMID 31724046, PMC 6853757 (freier Volltext).

drugbank.com (Global: 7,932nd place; German: low place)

go.drugbank.com

europa.eu (Global: 62nd place; German: 21st place)

ema.europa.eu

  • Summary of opinion: Fetcroja. CHMP, 27. Februar 2020 (PDF), abgerufen am 3. März 2020.

ec.europa.eu

fda.gov (Global: 470th place; German: 765th place)

accessdata.fda.gov

precision.fda.gov

fda.gov

nih.gov (Global: 5th place; German: 7th place)

ncbi.nlm.nih.gov

  • Stella Babich, Pier Giorgio Cojutti, Milo Gatti, Federico Pea, Stefano Di Bella, Jacopo Monticelli: Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis. In: JAC-Antimicrobial Resistance. Band 7, Nr. 3, 29. April 2025, doi:10.1093/jacamr/dlaf066, PMC 12050970 (freier Volltext).
  • T. Sato, K. Yamawaki: Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin. In: Clinical Infectious Diseases. Band 69, Supplement 7. November 2019, S. S538–S543, doi:10.1093/cid/ciz826, PMID 31724047, PMC 6853759 (freier Volltext).
  • Robert A Bonomo: Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens. In: Clinical Infectious Diseases. Band 69, Supplement_7, 13. November 2019, S. S519–S520, doi:10.1093/cid/ciz823, PMID 31724046, PMC 6853757 (freier Volltext).

pubchem.ncbi.nlm.nih.gov

pharmazeutische-zeitung.de (Global: low place; German: 730th place)

who.int (Global: 213th place; German: 245th place)

wikidata.org (Global: 10th place; German: 633rd place)